Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis. [electronic resource]
Producer: 20180523Description: 607-615 p. digitalISSN:- 1873-5010
- Adult
- Anti-Bacterial Agents -- therapeutic use
- Clinical Protocols -- standards
- Cystic Fibrosis -- complications
- Endpoint Determination -- methods
- Feasibility Studies
- Female
- Forced Expiratory Volume -- drug effects
- Humans
- Male
- Outcome Assessment, Health Care -- methods
- Randomized Controlled Trials as Topic -- methods
- Respiratory Tract Infections -- drug therapy
- Sample Size
- Surveys and Questionnaires -- standards
- Symptom Flare Up
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.